Precision medicine in clinical oncology: the journey from IgG antibody to IgE.

Fazekas-Singer, Judit; Singer, Josef; Jensen-Jarolim, Erika

Fazekas-Singer, Judit; Singer, Josef; Jensen-Jarolim, Erika.

Affiliation

Fazekas-Singer J; The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna.
Singer J; Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna.
Jensen-Jarolim E; Biomedical Image Facility, Institute for Science and Technology Austria, Klosterneuburg.

Curr Opin Allergy Clin Immunol ; 20(3): 282-289, 2020 06.

Article in En | MEDLINE | ID: mdl-32349107

Subject(s)

Antineoplastic Agents, Immunological/therapeutic use; Medical Oncology/methods; Neoplasms/drug therapy; Precision Medicine/methods; Radioimmunotherapy/methods; Antibodies, Bispecific/therapeutic use; Antibodies, Monoclonal/therapeutic use; Drug Resistance, Neoplasm/genetics; Humans; Immunoconjugates/therapeutic use; Immunoglobulin E/therapeutic use; Immunoglobulin Fc Fragments/therapeutic use; Medical Oncology/trends; Neoplasms/genetics; Neoplasms/immunology; Neoplasms/mortality; Precision Medicine/trends; Progression-Free Survival; Protein Engineering; Radioimmunotherapy/trends; Tumor Escape/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Radioimmunotherapy / Precision Medicine / Antineoplastic Agents, Immunological / Medical Oncology / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Opin Allergy Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2020 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google